Skip to content
10-Q

Quarterly Report

GAIN THERAPEUTICS, INC GANX

0001104659-25-110347

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 36.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 31.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 26.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.27M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$13.85M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$15.42M
Long Term Debt Q3 2025 · Sep 30, 2025 $298.8K
Long Term Debt Q3 2025 · Dec 31, 2024 $328.33K
Short Term Debt Q3 2025 · Sep 30, 2025 $125.55K
Short Term Debt Q3 2025 · Dec 31, 2024 $110.18K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $8.81M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $10.39M
Stockholders Equity Q3 2025 · Sep 30, 2025 $5.91M
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.7M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.34M
Stockholders Equity Q3 2025 · Sep 30, 2024 $8.91M
Stockholders Equity Q3 2025 · Jun 30, 2024 $11.78M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.17M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.91M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.06M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.78M
Current Assets Q3 2025 · Sep 30, 2025 $10.52M
Current Assets Q3 2025 · Dec 31, 2024 $11.6M
Total Assets Q3 2025 · Sep 30, 2025 $10.97M
Total Assets Q3 2025 · Dec 31, 2024 $12.12M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.15
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.78
Eps Basic Q3 2025 · Sep 30, 2025 −$0.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$0.17
Eps Basic Q3 2025 · Sep 30, 2024 −$0.78
Sga Expense Q3 2025 · Sep 30, 2025 $1.94M
Sga Expense Q3 2025 · Sep 30, 2025 $6.38M
Sga Expense Q3 2025 · Sep 30, 2024 $1.84M
Sga Expense Q3 2025 · Sep 30, 2024 $7.45M
Rd Expense Q3 2025 · Sep 30, 2025 $2.85M
Rd Expense Q3 2025 · Sep 30, 2025 $7.87M
Rd Expense Q3 2025 · Sep 30, 2024 $2.62M
Rd Expense Q3 2025 · Sep 30, 2024 $9.57M
Net Income Q3 2025 · Sep 30, 2025 −$5.28M
Net Income Q3 2025 · Sep 30, 2025 −$15.62M
Net Income Q3 2025 · Sep 30, 2024 −$4.49M
Net Income Q3 2025 · Sep 30, 2024 −$16.64M
Operating Income Q3 2025 · Sep 30, 2025 −$4.79M
Operating Income Q3 2025 · Sep 30, 2025 −$14.24M
Operating Income Q3 2025 · Sep 30, 2024 −$4.46M
Operating Income Q3 2025 · Sep 30, 2024 −$17.02M